BELIFT LAB said ENHYPEN member Sunoo will sit out the group’s Mexico City concert after a sudden decline in his condition.
ENHYPEN member Sunoo will not take part in the group’s Mexico City concert after experiencing a sudden decline in his condition, according to a new notice from BELIFT LAB. The agency said the decision was made because of health concerns and asked fans for understanding as the group continues its ENHYPEN WORLD TOUR “BLOOD SAGA” schedule.
The announcement places Sunoo’s health at the center of an otherwise high-profile international tour stop. ENHYPEN has been building momentum through its latest world tour, and Mexico City is one of the group’s major overseas dates. For fans who expected to see all members on stage, the update is a disappointment, but the agency’s wording made clear that recovery is the priority.
BELIFT LAB Confirms Sunoo’s Absence
In its statement, BELIFT LAB said Sunoo would be unable to participate in the Mexico City performance because his condition had worsened suddenly. The agency did not provide a detailed diagnosis, treatment plan, or timeline for his return, which is typical for brief health-related artist notices in the K-pop industry.
The company added that it would do its utmost to support Sunoo’s treatment and recovery so he can return to fans in good health. That language suggests the absence is being treated as a medical and rest matter rather than a long-term schedule change, though no further appearances have been confirmed or ruled out in the notice.
For ENGENEs, the group’s fandom, the immediate effect is straightforward: the Mexico City concert will proceed without Sunoo. The remaining members are expected to carry the performance, while the production may adjust formations, vocal parts, and stage blocking to account for his absence.
World Tour Schedules Put Health Decisions Under Scrutiny
Health-related absences have become an increasingly visible part of K-pop touring, especially as groups move quickly between cities, rehearsals, media commitments, and long-haul travel. A single concert can involve days of preparation, sound checks, choreography review, and promotional obligations before the show begins.
That pace can make even a short-term health issue difficult to manage. When an artist’s condition changes close to showtime, agencies often face a narrow decision window: continue with modified staging, postpone the event, or have the affected member sit out while the rest of the group performs. BELIFT LAB’s notice indicates it chose the last option for the Mexico City stop.
The decision also reflects the balance agencies must strike between ticket-holder expectations and artist welfare. Fans buy concert tickets to see complete group performances, but a member performing while unwell can risk a longer absence or a more serious setback. In that context, a temporary pause can be the more responsible choice even when it causes disappointment.
ENHYPEN Continues The “BLOOD SAGA” Tour
ENHYPEN is currently carrying out the “BLOOD SAGA” world tour, a new global run that has drawn attention from fans across multiple regions. The Mexico City stop is part of the group’s continuing overseas push, underscoring the group’s strong international demand and the logistical complexity that comes with maintaining a large-scale tour.
Sunoo has been a key presence in ENHYPEN’s performances, known for his expressive stage delivery and connection with fans. His absence will be noticeable, particularly in choreographed sections where each member’s position contributes to the group’s visual structure. Still, K-pop concert teams are accustomed to making rapid adjustments when health or safety issues arise.
As of the agency’s latest update, BELIFT LAB has not announced whether Sunoo’s absence will affect any additional stops or promotional activities. Fans will likely be watching official channels for further schedule notices, especially if the tour moves quickly to another city after Mexico.
For now, the central message from the agency is caution. Sunoo is stepping back from the Mexico City concert because of his condition, while BELIFT LAB says it will support his recovery so he can return when he is healthy enough to perform.
Comments